La catena delle opzioni mostra i dati chiave delle opzioni azionarie di NextPlat a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per NextPlat..

NextPlat (NASDAQ:NXPL) Azioni, Catena delle Opzioni

NextPlat

NextPlat Corp is an e-commerce and healthcare company. Its e-commerce venues form an effective network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operates in two segments: e-Commerce Operations involves acquiring and leasing an e-commerce platform; and Healthcare Operations provides TPA, data management, COVID-19 related diagnostics and vaccinations, prescription pharmaceuticals, and Others.

NextPlat Corp

Citigroup analyst Filippo Falorni maintains Estee Lauder Cos (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EL#NYSE">EL</a>) with a Neutral and raises the price target from $60 to $99.

News

Price Target

Analyst Ratings

Citigroup Maintains Neutral on Estee Lauder Cos, Raises Price Target to $99

POWL

Powell Industries Acquires Remsdaq Ltd. For A Total Consideration Of ~$16.3M

Portman Ridge Finance Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTMN#NASDAQ">PTMN</a>) ("Portman Ridge" or "PTMN") today announced the closing of the previously announced merger of Logan Ridge Finance Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LRFC#NASDAQ">LRFC</a>) ("Logan Ridge" or "LRFC") with and into PTMN, with PTMN remaining as the surviving company. Based on July 11, 2025 financial data, the combined company had total assets in excess of $600 million.
Ted Goldthorpe, President and Chief Executive Officer of PTMN and Head of the BC Partners Credit Platform, stated, "We would like to thank the shareholders and independent directors of both companies for their strong support throughout the merger process. With the merger now complete, we look forward to rebranding PTMN as BCP Investment Corporation later this summer, which will better reflect our affiliation with the broader BC Partners Credit Platform.
Looking forward, we are excited about the opportunities ahead. We will seek to leverage the combined company's enhanced scale, further diversified portfolio, cost savings due to lower overall operating expenses, and improved stock trading liquidity to deliver compelling risk-adjusted returns for our shareholders."
In connection with the closing of the merger, LRFC shareholders are entitled to receive approximately 4.0 million shares of PTMN common stock in the aggregate, or 1.5 shares of PTMN common stock for each common share of LRFC, based on the applicable exchange ratio and payment of cash in lieu of fractional shares.
Prior to the closing of the merger, LRFC's investment adviser announced a cash payment of $0.47 per share to LRFC shareholders of record as of May 6, 2025, which is expected to be paid to the applicable legacy LRFC shareholders on or about July 25, 2025. Additionally, on July 14, 2025, LRFC's Board of Directors declared a tax distribution of $0.38 per share to LRFC shareholders of record as of July 14, 2025, which is expected to be paid to the applicable legacy LRFC shareholders on or about July 22, 2025.

LRFC

PTMN

Portman Ridge Finance Corporation Closes Previously Announced Merger With Logan Ridge Finance Corporation

Transaction Update: AAM Stockholders Approve Proposed Combination
DETROIT, July 15, 2025 /PRNewswire/ --&nbsp;American Axle &amp; Manufacturing Holdings, Inc. ("AAM"), (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AXL#NYSE">AXL</a>)&nbsp;today announced that at a special meeting (the "Special Meeting") of its stockholders ("AAM Stockholders") held in connection with AAM's recommended offer to acquire the entire issued and to be issued share capital of Dowlais Group plc ("Dowlais"), (the "Combination"), AAM Stockholders approved all proposals related to the Combination as described in AAM's definitive proxy statement on Schedule 14A filed with the U.S. Securities and Exchange Commission (the "SEC") on June 2, 2025, as amended and supplemented pursuant to Current Reports on Form 8-K filed by AAM with the SEC on June 9, 2025 and July 7, 2025. Dowlais shareholders are expected to vote on the Scheme and Special Resolution at the Court Meeting and General Meeting, respectively, on July 22, 2025.
In addition, as announced on May 16, 2025, AAM intends to seek a secondary listing and admission of shares of its common stock, par value $0.01 per share (collectively, "AAM Shares"), including the new AAM Shares to be issued in connection with the Combination, to trading on the London Stock Exchange. Following the Combination, the combined AAM and Dowlais group will have an expanded and balanced geographic presence across multiple automotive segments supporting ICE, hybrid and electric powertrains and is expected to generate annual revenues of approximately $12 billion on a non-adjusted combined basis.
Antitrust and other regulatory approvals continue to progress, and the deal is anticipated to close in the fourth quarter of 2025, subject to Dowlais shareholder approval and the completion of the other remaining conditions.

American Axle Stockholders Approve All Proposals Related To Dowlais Acquisition At Special Meeting

STAI

ScanTech AI Receives Nasdaq Deficiency Notice

Citigroup analyst Filippo Falorni maintains Kenvue (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KVUE#NYSE">KVUE</a>) with a Neutral and lowers the price target from $24.5 to $22.

KVUE

Citigroup Maintains Neutral on Kenvue, Lowers Price Target to $22

TechnipFMC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FTI#NYSE">FTI</a>) has been awarded a significant(1) integrated Engineering, Procurement, Construction, and Installation (iEPCI&#x2122;) contract by Equinor for its Heidrun extension project in the Norwegian North Sea.
The award follows an integrated Front End Engineering and Design (iFEED&#x2122;) study by TechnipFMC. The project will enhance the current infrastructure and extend the production lifecycle for the Heidrun platform.
Jonathan Landes, President, Subsea at TechnipFMC commented: "This direct award highlights the mutual benefit of early engagement, which led to an optimized field layout. We are excited to leverage our iEPCI&#x2122; integrated execution to upgrade this important asset for Equinor."
(1) For TechnipFMC, a "significant" contract is between $75 million and $250 million. This award was included in inbound orders in the second quarter of 2025.

Contracts

Global

EQNR

TechnipFMC Wins iEPCI Contract From Equinor For Heidrun Extension In Norwegian North Sea; Contract Is Between $75M And $250M

Dividends

JBSS

John B. Sanfilippo & Son, Declares $0.60/Share Special Dividend

<a href="https://www.benzinga.com/topic/china">China&#8217;s economy expanded</a> by 5.2% in the second quarter of 2025, slightly better than expected and just enough to spark cautious optimism in global markets. Although the number exceeds the 5.1% economists forecast, according to a Reuters poll, it also represents a slight deceleration from Q1&#8217;s 5.4% rate, as cited by CNBC. In short, China&#8217;s okay: not booming, not crashing.
But, for ETF investors, the devil is in the policy details.
While the economy overall is well on its way to achieving Beijing&#8217;s 5% full-year growth target, Chinese policymakers are temporarily giving themselves a rest from yet another stimulus. That alters the math for investors owning, or considering, China-themed ETFs. Some will flourish in this &#8220;wait-and-watch&#8221; scenario; others will stagnate until Beijing deploys its next fiscal stimulatory dose.
Let&#8217;s dissect the terrain.
Also Read:<a href="https://www.benzinga.com/etfs/sector-etfs/25/07/46423852/nvidias-china-chip-deal-signals-new-tailwind-for-chip-and-ai-etfs"> Nvidia&#8217;s China Chip Deal Signals New Tailwind For Chip And AI ETFs</a>
<h2 class="wp-block-heading">Exports Are Up, And So Are Certain ETFs</h2>
Among the quiet heroes of Q2 is China&#8217;s export machine. In spite of the geopolitical tensions surrounding it, China was able to increase exports to Southeast Asia by 13%, and exports to the European Union by 6.6%. The numbers suggest strength in China&#8217;s position as a global supplier, even with weak domestic demand.
And that bodes well for broad China ETFs such as,
<ul class="wp-block-list">
<li>iShares MSCI China ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCHI#NASDAQ">MCHI</a>): Provides diversified exposure to Chinese firms across industries, such as industrials, consumer discretionary, and technology. The fund is up 2% as of Tuesday&#8217;s publication.</li>
<li>iShares China Large-Cap ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FXI#NYSE">FXI</a>): Tracks the 50 largest Chinese securities listed on the Hong Kong Stock Exchange, which is a more export-sensitive vehicle. The fund was close behind MCHI, gaining almost 2% as of Tuesday&#8217;s writing.</li>
</ul>
Why they&#8217;re worth watching: These ETFs may continue to thrive if trade holds up and global supply chains remain fairly stable. If Beijing continues to prioritize helping industry and manufacturing over consumer segments, big caps and exporters may be among the early beneficiaries.
Also Read: <a href="https://www.benzinga.com/markets/tech/25/07/46409079/nvidia-growth-estimates-get-10-boost-as-us-lifts-china-chip-export-curbs-gene-munster-predicts-30-35-growth-for-2026">Nvidia Growth Estimates Get 10% Boost As US Lifts China Chip Export Curbs: Gene Munster Predicts 30-35% Growth For 2026</a>
<h2 class="wp-block-heading">Domestic Demand Still In The Doldrums</h2>
Although exports were strong, Chinese consumer consumption is still not strong enough. That&#8217;s bad news for investors hoping for a recovery in e-commerce, technology services, or discretionary retail.
However, ETFs such as these still have long-term potential:
<ul class="wp-block-list">
<li>KraneShares CSI China Internet ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KWEB#NYSE">KWEB</a>): Follows Chinese internet stocks like Alibaba (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>), JD.com (OTCPK: JDCMF), and Tencent (OTPK: TCEHY). The fund gained 4% Tuesday afternoon.</li>
<li>Invesco China Technology ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CQQQ#NYSE">CQQQ</a>): Provides access to Chinese technology and communications companies, some of which rely more heavily on domestic consumers than on international trade. The fund was up 3.2% on Tuesday.</li>
</ul>
The Catch? These ETFs are also more sensitive to domestic demand and confidence. With real estate remaining weak and youth unemployment persisting, consumer spending is likely to remain subdued unless Beijing introduces targeted stimulus measures aimed at households. Analysts are speculating that such action, if it materializes, might be timed for September, CNBC reported.
<h2 class="wp-block-heading">Policy-Driven Plays</h2>
Another route to betting on Chinese stimulus (or not) is through A-shares: shares of mainland Chinese companies listed on exchanges such as the Shanghai and Shenzhen.
Xtrackers Harvest CSI 300 China A-Shares ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASHR#NYSE">ASHR</a>): Follows the performance of the CSI 300 Index, an index of the 300 largest and most liquid stocks in mainland China. ASHR is particularly sensitive to policy shifts. Any future fiscal support directed at infrastructure, state-owned enterprises, or domestic industries could directly benefit these companies, and in turn, this ETF.
That said, there is a point to note. ASHR tends to respond more quickly to Chinese policy decisions than more internationally exposed ETFs, such as FXI or MCHI. If you're expecting stimulus, this could be your "policy play."
<h2 class="wp-block-heading">The Stimulus Watch</h2>
So far, Beijing has resisted the urge to unleash a major new round of economic support. Some of this caution stems from Q2's relatively stable growth, but it also reflects concerns about long-term debt levels and the effectiveness of past stimulus efforts.
Nevertheless, the pressure is mounting. In its latest <a href="https://research.nus.edu.sg/eai/wp-content/uploads/2025/07/EAIC-93-20250711-English_Chinese-2-1.pdf">report</a>, People&#8217;s Bank of China advisor Huang Yiping demanded as much as 1.5 trillion yuan of fiscal stimulus, mainly to lift consumers&#8217; spending.
September is now under the markets&#8217; radar, that is when the next batch of stimulus might arrive if the economic pace is seen to decelerate.
Until that point, ETFs with exposure to exports, industrials with large market capitalizations, or sectors boosted by the recent trade truce (such as rare earths and semiconductors) might be in the driver&#8217;s seat.
In April, U.S.-China tariffs jumped to an astronomical 145%, prompting a temporary market panic. By May, however, the two nations negotiated a temporary middle ground. If this detente solidifies into a full-fledged trade agreement by the August 12 deadline, tech-biased ETFs such as CQQQ and KWEB may gain from heightened cross-border flows and reduced regulatory risk.
<h2 class="wp-block-heading">Final Thoughts</h2>
The Q2 GDP surprise buys Beijing some time, and for the time being, that means selectivity is key. One can consider holding onto ETFs with exposure to what&#8217;s performing (exports, large caps), but watch domestic-hedged funds that may come roaring back to life if fiscal stimulus arrives later this year.
In China, as in the markets, the next big move is never about the numbers; it&#8217;s always about what policymakers do next.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/movers/25/07/46413630/chinese-stocks-see-broad-rally-as-us-eases-chip-curbs">Chinese Stocks See Broad Rally As US Eases Chip Curbs</a></li>
</ul>
Photo: Shutterstock

Emerging Market ETFs

ETFs

ASHR

BABA

CQQQ

JDCMF

KWEB

MCHI

TCEHY

iShares Trust Barclays 20+ Year Treasury Bond Fund

China's GDP Growth Beats Expectations, But Which ETFs Will Actually Benefit?

WIIM

NUWE

Nuwellis shares are trading higher after the company announced it secured a U.S. patent for an extracorporeal blood filtering machine and methods.

PAVS

Paranovus Receives Nasdaq Noncompliance Notice

<a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4468805-1&amp;h=2209695135&amp;u=https%3A%2F%2Fdoverfuelingsolutions.com%2F&amp;a=Dover+Fueling+Solutions+(%22DFS%22)">Dover Fueling Solutions ("DFS")</a>, a part of <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4468805-1&amp;h=1798565847&amp;u=https%3A%2F%2Fwww.dovercorporation.com%2F&amp;a=Dover">Dover</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOV#NYSE">DOV</a>) and a leading global provider of advanced customer-focused technologies, services and solutions in the fuel and convenience retail industries, today announced a global partnership agreement with Bottomline to bring the <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4468805-1&amp;h=2842414261&amp;u=https%3A%2F%2Fwww.doverfuelingsolutions.com%2Fna%2Fen%2Fproducts-and-solutions%2Fasset-management%2Fbx-platform.html&amp;a=BX+platform">BX platform</a>, a cutting-edge supply chain optimization solution, to fuel retailers worldwide.
DFS and Bottomline's partnership in Europe has helped customers save money since 2023. The companies are now expanding their successful partnership to benefit fuel retail businesses globally.
 &nbsp;

Dover's Dover Fueling Solutions Partners With Bottomline To Bring BX Platform, Supply Chain Optimization Solution, To Fuel Retailers Worldwide

Citigroup analyst Filippo Falorni maintains Molson Coors Beverage (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TAP#NYSE">TAP</a>) with a Neutral and lowers the price target from $56 to $51.

Citigroup Maintains Neutral on Molson Coors Beverage, Lowers Price Target to $51

AUDUBON, Pa., July 15, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GMED#NYSE">GMED</a>), a leading musculoskeletal solutions company, today announced the expanded Excelsius&#x2122;&nbsp;navigation capabilities of its next-generation oscillating system, DuraPro&#x2122;, as the latest addition to the Power Portfolio, designed to advance procedural workflows through safety features and efficiency.
"Our goal is to revolutionize the $550 million high-speed drill market with the introduction of innovative, next generation oscillation," said&nbsp;David Hole, president of spine at Globus Medical. "The DuraPro&#x2122; oscillating system coupled with navigation enhances the procedural solutions we offer to surgeons to help advance patient care.
With its cutting-edge oscillating technology, DuraPro&#x2122; helps prevent soft tissue wrapping while retaining a natural sensation akin to that of conventional spinning drills. This system provides surgeons with instruments for efficient, accurate cutting to remove bone, while utilizing oscillating technology to help safeguard delicate tissue. It also features anti-skiving pilot hole drilling; the oscillating nature of the technology allows for drill tips to maintain trajectories without deviating from the starting point, and the brush attachments facilitate thorough discectomies. The versatile system seamlessly integrates with ExcelsiusGPS&#x2122; and ExcelsiusHub&#x2122; to support accuracy, efficiency and confidence across navigated and non-navigated workflows.
"DuraPro&#x2122; allows us to navigate around delicate structures with greater confidence during decompressions," share Drs. Roland Kent and David Glassman of Axis Spine Center in Cour D'Alene, Idaho. "The integration with ExcelsiusGPS&#x2122; takes it a step further—providing real-time visualization for accuracy while reinforcing the safety benefits of oscillating technology."
In addition to DuraPro&#x2122;, Globus Medical launched Verzera&#x2122;, a navigated high-speed drill system integrated with the ExcelsiusGPS and ExcelsiusHub system. Verzera&#x2122; augments existing workflows for surgeons utilizing Globus' enabling technologies, by allowing them to navigate bone removal during procedures.
The expanded Globus Medical Power Portfolio represents the Company's continued commitment to solving unmet clinical needs and delivering surgeons with added confidence through procedurally integrated technology. Learn more about the Power Portfolio <a href="https://www.globenewswire.com/Tracker?data=bRqJFUzyeQW9cIGe2i3WNSHSahXUkqyT_9xUq4xaRAkhIILk6LYP6FlIWjqm7t1r2EU3XbmsBuiimOXs1tlofJsH93DHzfMTJY8PEwZjDTMaHEZEsRddmcE0luF5JKlH__BsMp8uz3-_B_wONGsY6A==">here</a>.

General

GMED

Globus Medical Reveals DuraPro With Navigation, A Next-Generation, Oscillating System Designed To Safeguard Delicate Tissue

LWLG

Lightwave Announces Its Perkinamine Polymer Has Passed The Telcordia 85/85 Test

Citigroup analyst Filippo Falorni maintains Newell Brands (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NWL#NASDAQ">NWL</a>) with a Neutral and raises the price target from $5 to $6.

Citigroup Maintains Neutral on Newell Brands, Raises Price Target to $6

Stock Split

IKNA

Ikena Oncology Announces Stockholder Approval Of Merger With Inmagene Biopharmaceuticals; Co. Announces 1-for-12 Reverse Stock Split Of Ikena Common Stock

Park Aerospace (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PKE#NYSE">PKE</a>) reported quarterly earnings of $0.10 per share. This is a 11.11 percent increase over earnings of $0.09 per share from the same period last year. The company reported $15.400 million in sales this quarter. This is a 10.24 percent increase over sales of $13.970 million the same period last year.

Earnings

Park Aerospace Q1 Adj. EPS $0.10 Up From $0.09 YoY, Sales $15.400M Up From $13.970M YoY

Shares of Longevity Health Holdings Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XAGE#NASDAQ">XAGE</a>) surged on Tuesday afternoon following the announcement of its definitive merger agreement with plasma collection leader True Health Inc.
What To Know: The <a href="https://www.benzinga.com/pressreleases/25/07/g46404398/longevity-health-holdings-announces-merger-with-thplasma-and-termination-of-2020-biolabs-transacti">all-stock transaction</a> will see the combined entity continue trading on Nasdaq under the XAGE ticker. This strategic pivot follows Longevity Health&#8217;s mutual termination of a previously announced merger with 20/20 BioLabs. The new deal with True Health, which operates as THPlasma, aims to leverage plasma synergies to drive bioaesthetic innovation.
This merger builds on Longevity&#8217;s recent acquisitions of Carmell Therapeutics and Elevai Skincare, which have technologies that utilize plasma-derived growth factors and exosomes. THPlasma plays a role in addressing the U.S. shortfall of plasma-derived therapeutics.
CEO George Chi called the merger a &#8220;transformative step expected to supercharge our growth by unlocking access to public markets.&#8221; 
XAGE Price Action: According to data from&nbsp;<a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, Longevity Health shares closed Tuesday up 115.50% to $5.70. The stock has a 52-week high of $59.10 and a 52-week low of $2.20.
Read Also: <a href="https://www.benzinga.com/money/best-healthcare-stocks">Best Healthcare Stocks Right Now</a>
<h2 class="wp-block-heading">How To Buy XAGE Stock</h2>
By now, you're likely curious about how to participate in the market for Longevity Health Holdings — be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of <a href="https://www.benzinga.com/money/best-stock-trading-platforms">possible trading platforms here.</a> Many will allow you to buy &#8220;fractional shares,&#8221; which allows you to own portions of stock without buying an entire share.
In the case of Longevity Health Holdings, which is trading at $5.50 this afternoon, $100 would buy you 18.18 shares of stock.
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform or a broker who will allow you to &#8220;go short&#8221; a share of stock by lending you the shares to sell. The process of shorting a <a href="https://www.benzinga.com/money/how-to-short-a-stock">stock can be found at this resource.</a> Otherwise, if your broker allows you to trade options, you can either buy a put option or sell a call option at a strike price above where shares are currently trading; either way, it allows you to profit from the share price decline.
Image: Shutterstock

Biotech

Health Care

Movers

Trading Ideas

Longevity Health Holdings, Inc. - Common Stock

XAGE

Why Longevity Health Stock Is Skyrocketing Today

Nicolet Bankshares (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NIC#NYSE">NIC</a>) reported quarterly earnings of $2.35 per share which beat the analyst consensus estimate of $2.15 by 9.05 percent. This is a 25 percent increase over earnings of $1.88 per share from the same period last year. The company reported quarterly sales of $75.109 million which beat the analyst consensus estimate of $72.729 million by 3.27 percent. This is a 14.95 percent increase over sales of $65.342 million the same period last year.

Earnings Beats

Nicolet Bankshares Q2 Adj. EPS $2.35 Beats $2.15 Estimate, Sales $75.109M Beat $72.729M Estimate

Press Releases

NextPlat Reports $65.5 Million in Consolidated Year-End 2024 Revenue

NextPlat's Global Telesat Awarded New UK Government Contract for Iridium Extreme® Push to Talk Devices

NextPlat Provides Statement on U.S. Tariff Impact on its E-Commerce Development Program

NextPlat's Global Telesat Receives Connectivity Services Contract Extension from Military Customer

NextPlat Corp Receives Nasdaq Notification Regarding Minimum Bid Requirements

NextPlat to Release First Quarter 2025 Results on Thursday, May 15, 2025

NextPlat Reports First Quarter 2025 Results

NextPlat's Global Telesat Named Exclusive UK and EU Distributor for ZOLEO Satellite Communicators, Further Expanding its Global Network of Connectivity Solution Partnerships

NextPlat Issues Statement on the Passing of its Executive Chairman and CEO Charles M. Fernandez

Small Cap

NextPlat Issues Interim CEO Update Shareholder Letter

NXPL

AST SpaceMobile, Inc. - Class A Common Stock

AST SpaceMobile

Anterix

Bandwidth

Cogent Communications Holdings, Inc. - Common Stock

Cogent Comms Hldgs

Globalstar

iOThree

iQSTEL

Iridium Communications Inc - Common Stock

Iridium Communications

Liberty Global Ltd. - Class A Common Shares

Liberty Global

Liberty Global Ltd. - Class B Common Shares

Liberty Global Ltd. - Class C Common Shares

Liberty Latin America Ltd. - Class A Common Stock

Liberty Latin America

Liberty Latin America Ltd. - Class C Common Stock

Lumen Technologies

Sify Technologies Limited - American Depository Shares, each represented by one Equity Share

Comments

NextPlat

NextPlat (NXPL) Opzioni

No option chain data available. Please try again later

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO